Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05019508 · ClinicalTrials.gov registry record
Fetal Cardiac Function Parameters and HbA1c As Screening for Gestational Diabetes Mellitus
A clinical trial, sponsored by University of Virginia.
- Completed
- Registry status
- 114
- Enrollment target
NCT05019508 is a clinical trial that has completed, run by University of Virginia. The registered enrollment target is 114 participants.
The verdict
NCT05019508 has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- 114 participants
- Enrollment target
Study Summary
This is a prospective cohort study to assess the predictive value of fetal cardiac parameters, the change in fetal cardiac parameters (CFP), HbA1c, and/or the change in HbA1c (ΔHbA1c) for gestational diabetes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2021-08-13 |
| Est. Completion | 2023-04-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05019508
The ClinicalTrials.gov registry entry for NCT05019508 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 114 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05019508 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05019508 about?
NCT05019508 is a clinical study titled "Fetal Cardiac Function Parameters and HbA1c As Screening for Gestational Diabetes Mellitus". This is a prospective cohort study to assess the predictive value of fetal cardiac parameters, the change in fetal cardiac parameters (CFP), HbA1c, and/or the change in HbA1c (ΔHbA1c) for gestational diabetes.
What is the current status of trial NCT05019508?
This trial is currently completed. The enrollment target is 114 participants. The study started on 2021-08-13. Estimated completion is 2023-04-10.
Who is sponsoring clinical trial NCT05019508?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.